News and updates from www.palliativedrugs.com

07/04/2017 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Hot topics Cochrane review: pharmacological interventions for pruritus in adult palliative care patients In this update to the original review in 2013, the authors concluded that there were was low–moderate […]

Read More…

Menkel’s Kinky Hair versus Dilnott Fairer Care – Journeys through Nuncupation

It’s eponymous my dear Watson! Eponymous adjective 1. (of a person) giving their name to something. “the eponymous hero of the novel” 2. (of a thing) named after a particular person or group. “their eponymous debut LP” Medical students of a certain vintage will have used the Oxford Handbook of Clinical Medicine. There was a […]

Read More…

It’s good to talk and even better to communicate effectively

by Dr Ollie Minton, Macmillan consultant and honorary senior lecturer in palliative medicine I remember the old British Telecom adverts moving from Maureen Lipman’s “ooh he’s got an ology” to the final incarnation of Bob Hoskins “It’s good to talk”. I’m fairly certain after this, the internet took off and the simple phone call was […]

Read More…

Kate Granger

by Dr Mark Taubert, Consultant in Palliative Medicine, Velindre Cancer Centre, Cardiff On  July 23, 2016, Dr. Kate Granger died at St Gemma’s Hospice. Goodbye  Kate. Some words. Where can we live, but days? A message you sent me in October 2013 read, “I have high expectations of myself & what I can achieve – I […]

Read More…

The Digital Legacy Conference 2016

By Sandy Weatherburn, ‎Founder & Director at Social Embers Digital estate management   This weekend I attended the Digital Legacy Conference in Hackney, London, which was held at St Joseph’s Hospice. The conference was organised by The Digital Legacy Association (DLA) to raise awareness of issues surrounding death and dying that are becoming increasingly important in […]

Read More…